COMPARISON OF THE INVITRO DISSOLUTION PROPERTIES AND INVIVO STEADY-STATE PHARMACOKINETICS OF 2 SUSTAINED-RELEASE THEOPHYLLINE PREPARATIONS

被引:0
|
作者
JONKMAN, JHG [1 ]
VANDERBOON, WJV [1 ]
GRASMEIJER, G [1 ]
机构
[1] PHARMA BIORES INT BV,DEPT BIOPHARMACEUT & CLIN PHARMACOL,9400 AC ASSEN,NETHERLANDS
关键词
D O I
10.1007/BF01966430
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:17 / 21
页数:5
相关论文
共 50 条
  • [31] STEADY-STATE PHARMACOKINETICS OF 2 SUSTAINED-RELEASE THEOPHYLLINE PRODUCTS DURING ONCE-DAILY AND TWICE-DAILY DOSING
    ARMSTRONG, EP
    NAKO, N
    PLEZIA, PM
    KRAMER, TH
    JONES, WN
    [J]. CLINICAL PHARMACY, 1987, 6 (10): : 800 - 804
  • [32] Comparative steady-state bioavailability of sustained-release theophylline preparations:: Theo-Dur®, Uni-Dur® and Xanthium®
    Rojanasthien, N
    Kovjiriyapan, K
    Manorot, M
    Pothirat, C
    [J]. ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2001, 19 (02): : 69 - 78
  • [33] STEADY-STATE KINETICS OF SUSTAINED-RELEASE PHENYLPROPANOLAMINE
    LONNERHOLM, G
    GRAHNEN, A
    LINDSTROM, B
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1984, 22 (01) : 39 - 41
  • [34] INFLUENCE OF PENTOXIFYLLINE ON STEADY-STATE THEOPHYLLINE SERUM CONCENTRATIONS FROM SUSTAINED-RELEASE FORMULATIONS
    ELLISON, MJ
    HORNER, RD
    WILLIS, SE
    CUMMINGS, DM
    [J]. PHARMACOTHERAPY, 1990, 10 (06): : 383 - 386
  • [35] STEADY-STATE EVALUATION OF THE MEAN RESIDENCE AND ABSORPTION TIMES OF 2 SUSTAINED-RELEASE THEOPHYLLINE PRODUCTS (SRT)
    SACCAR, CL
    ROCCI, ML
    MANSMANN, HC
    [J]. ANNALS OF ALLERGY, 1985, 55 (02): : 227 - 227
  • [36] INVITRO DISSOLUTION BEHAVIOR OF SOME SUSTAINED-RELEASE THEOPHYLLINE DOSAGE FORMS
    LIN, SY
    YANG, JC
    [J]. PHARMACEUTICA ACTA HELVETIAE, 1989, 64 (08): : 236 - 240
  • [37] Tramadol Steady-State Pharmacokinetics of Immediate-Release Capsules and Sustained-Release Tablets in Dogs
    Winter, Esther
    van Geijlswijk, Ingeborg
    Akkerdaas, Ies
    Sturkenboom, Marieke
    Gehring, Ronette
    [J]. FUTURE PHARMACOLOGY, 2022, 2 (04): : 660 - 668
  • [38] STEADY-STATE BIOAVAILABILITY OF 2 SUSTAINED-RELEASE QUINIDINE PREPARATIONS - QUINIDINE GLUCONATE VERSUS QUINIDINE SULFATE
    TAGGART, WV
    HOLYOAK, W
    [J]. CLINICAL THERAPEUTICS, 1983, 5 (04) : 357 - 364
  • [39] PHARMACOKINETICS AND DRUG-MONITORING DURING THE DEVELOPMENT OF SUSTAINED-RELEASE PREPARATIONS OF THEOPHYLLINE
    IWAINSKY, H
    WILKE, A
    WEIDE, W
    SCHAFER, K
    [J]. PHARMAZIE, 1987, 42 (04): : 242 - 244
  • [40] PHARMACOKINETICS OF ENPROFYLLINE ADMINISTERED INTRAVENOUSLY AND AS A SUSTAINED-RELEASE TABLET AT STEADY-STATE IN CHILDREN WITH ASTHMA
    WATSON, WTA
    SIMONS, KJ
    SIMONS, FER
    [J]. JOURNAL OF PEDIATRICS, 1988, 112 (04): : 658 - 662